Safwan Kezbor M.d.

Safwan Kezbor, M.D. has a diverse work experience in the field of clinical research and development. Safwan began their career in 2011 as a Postgraduate Clinical Research Fellow at Columbia University, where they worked until 2013. Following this, they joined Mount Sinai Health System and served in various roles including Global Clinical Project Lead, Clinical Research Lead, and Postgraduate Clinical Research Fellow until 2017.

In 2017, Dr. Kezbor transitioned to Biotrial, where they worked as the U.S. Clinical Operations Lead and Clinical Research Project Lead until 2019. Safwan then joined Amicus Therapeutics as an Associate Medical Director, Clinical Research from 2019 to 2020.

Currently, Dr. Kezbor is working at Shionogi Inc. Safwan started as a Medical Director, Clinical Development in August 2020, and later got promoted to Senior Medical Director, Clinical Development in April 2023. Shionogi Inc. is a pharmaceutical company based in the United States.

Overall, Safwan Kezbor, M.D. has extensive experience in clinical research and development, having held positions of increasing responsibility in both academic and industry settings.

Safwan Kezbor, M.D. earned their Doctor of Medicine (MD) degree in Medicine from Aleppo University from 2003 to 2011. In 2010, they completed an elective clinical rotation in Neurology at UT Southwestern Medical Center and also briefly attended Baylor College of Medicine. In 2011, they attended Icahn School of Medicine at Mount Sinai, although the specific degree and field of study are not provided.

Safwan Kezbor, M.D. has also obtained additional certifications throughout their career. In 2011, they obtained the certification of Certified M.D. from the Educational Commission for Foreign Medical Graduates (ECFMG). In 2013, they completed a certification program in clinical study protocols designing from Columbia University in the City of New York. In 2015, they obtained the Certified Clinical Research Professional (CCRP) certification from the Society of Clinical Research Associates (SOCRA). In 2019, they completed two certifications: "The Science of Clinical Outcome Assessment (COA) in Medical Product Development" from the University of Maryland and "Medical coding & Safety data analysis SMQ" from MedDRA MSSO. In 2021, they completed two additional certifications: "Exercising Leadership: Foundational Principles" and "Prescription Drug Regulation, Cost, and Access: Current Controversies in Context" from Harvard University.